Great Point Partners Llc Buys Galapagos NV, Relmada Therapeutics Inc, Sarepta Therapeutics Inc, Sells , , United Therapeutics Corp

Author's Avatar
Feb 16, 2022
Article's Main Image
Greenwich, CT, based Investment company Great Point Partners Llc (Current Portfolio) buys Galapagos NV, Relmada Therapeutics Inc, Sarepta Therapeutics Inc, Bicycle Therapeutics PLC, Avidity Biosciences Inc, sells , , United Therapeutics Corp, Biogen Inc, Sage Therapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Great Point Partners Llc. As of 2021Q4, Great Point Partners Llc owns 36 stocks with a total value of $450 million. These are the details of the buys and sells.

For the details of GREAT POINT PARTNERS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/great+point+partners+llc/current-portfolio/portfolio

These are the top 5 holdings of GREAT POINT PARTNERS LLC
  1. Arena Pharmaceuticals Inc (ARNA) - 530,670 shares, 10.96% of the total portfolio.
  2. Exelixis Inc (EXEL) - 1,750,000 shares, 7.11% of the total portfolio. Shares added by 14.75%
  3. Xenon Pharmaceuticals Inc (XENE) - 950,000 shares, 6.59% of the total portfolio. Shares added by 35.71%
  4. Travere Therapeutics Inc (TVTX) - 800,000 shares, 5.52% of the total portfolio. Shares added by 28.00%
  5. AnaptysBio Inc (ANAB) - 592,250 shares, 4.57% of the total portfolio. Shares added by 7.77%
New Purchase: Galapagos NV (GLPG)

Great Point Partners Llc initiated holding in Galapagos NV. The purchase prices were between $47.03 and $57.12, with an estimated average price of $52.17. The stock is now traded at around $66.700000. The impact to a portfolio due to this purchase was 3.67%. The holding were 300,000 shares as of 2021-12-31.

New Purchase: Relmada Therapeutics Inc (RLMD)

Great Point Partners Llc initiated holding in Relmada Therapeutics Inc. The purchase prices were between $16.93 and $26.82, with an estimated average price of $22.13. The stock is now traded at around $19.815000. The impact to a portfolio due to this purchase was 3.59%. The holding were 717,320 shares as of 2021-12-31.

New Purchase: Sarepta Therapeutics Inc (SRPT)

Great Point Partners Llc initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $77.28 and $99.42, with an estimated average price of $85.35. The stock is now traded at around $80.075000. The impact to a portfolio due to this purchase was 2.91%. The holding were 145,405 shares as of 2021-12-31.

New Purchase: Bicycle Therapeutics PLC (BCYC)

Great Point Partners Llc initiated holding in Bicycle Therapeutics PLC. The purchase prices were between $41.7 and $61.14, with an estimated average price of $55.41. The stock is now traded at around $47.730000. The impact to a portfolio due to this purchase was 2.7%. The holding were 200,000 shares as of 2021-12-31.

New Purchase: Avidity Biosciences Inc (RNA)

Great Point Partners Llc initiated holding in Avidity Biosciences Inc. The purchase prices were between $20.4 and $28.66, with an estimated average price of $23.92. The stock is now traded at around $16.300000. The impact to a portfolio due to this purchase was 2.64%. The holding were 500,000 shares as of 2021-12-31.

New Purchase: Silence Therapeutics PLC (SLN)

Great Point Partners Llc initiated holding in Silence Therapeutics PLC. The purchase prices were between $20.61 and $25.71, with an estimated average price of $22.89. The stock is now traded at around $21.690000. The impact to a portfolio due to this purchase was 2.36%. The holding were 444,443 shares as of 2021-12-31.

Added: Vaxcyte Inc (PCVX)

Great Point Partners Llc added to a holding in Vaxcyte Inc by 409.89%. The purchase prices were between $19.32 and $26.45, with an estimated average price of $23.19. The stock is now traded at around $20.040000. The impact to a portfolio due to this purchase was 2.12%. The holding were 500,000 shares as of 2021-12-31.

Added: ProQR Therapeutics NV (PRQR)

Great Point Partners Llc added to a holding in ProQR Therapeutics NV by 3595.68%. The purchase prices were between $6.58 and $8.44, with an estimated average price of $7.61. The stock is now traded at around $1.189900. The impact to a portfolio due to this purchase was 1.95%. The holding were 1,121,122 shares as of 2021-12-31.

Added: Rigel Pharmaceuticals Inc (RIGL)

Great Point Partners Llc added to a holding in Rigel Pharmaceuticals Inc by 152.53%. The purchase prices were between $2.36 and $3.57, with an estimated average price of $3.01. The stock is now traded at around $2.540000. The impact to a portfolio due to this purchase was 1.78%. The holding were 5,000,000 shares as of 2021-12-31.

Added: Xenon Pharmaceuticals Inc (XENE)

Great Point Partners Llc added to a holding in Xenon Pharmaceuticals Inc by 35.71%. The purchase prices were between $24.73 and $35.4, with an estimated average price of $30.08. The stock is now traded at around $32.720000. The impact to a portfolio due to this purchase was 1.73%. The holding were 950,000 shares as of 2021-12-31.

Added: Travere Therapeutics Inc (TVTX)

Great Point Partners Llc added to a holding in Travere Therapeutics Inc by 28.00%. The purchase prices were between $24.34 and $31.17, with an estimated average price of $28.29. The stock is now traded at around $27.800000. The impact to a portfolio due to this purchase was 1.21%. The holding were 800,000 shares as of 2021-12-31.

Added: Aclaris Therapeutics Inc (ACRS)

Great Point Partners Llc added to a holding in Aclaris Therapeutics Inc by 60.00%. The purchase prices were between $12.27 and $18.49, with an estimated average price of $15.09. The stock is now traded at around $12.730000. The impact to a portfolio due to this purchase was 0.97%. The holding were 800,000 shares as of 2021-12-31.

Sold Out: (KDMN)

Great Point Partners Llc sold out a holding in . The sale prices were between $8.54 and $9.5, with an estimated average price of $9.15.

Sold Out: (DRNA)

Great Point Partners Llc sold out a holding in . The sale prices were between $19.26 and $38.25, with an estimated average price of $29.18.

Sold Out: United Therapeutics Corp (UTHR)

Great Point Partners Llc sold out a holding in United Therapeutics Corp. The sale prices were between $184.32 and $216.08, with an estimated average price of $196.8.

Sold Out: Biogen Inc (BIIB)

Great Point Partners Llc sold out a holding in Biogen Inc. The sale prices were between $223.92 and $287.77, with an estimated average price of $256.27.

Sold Out: Sage Therapeutics Inc (SAGE)

Great Point Partners Llc sold out a holding in Sage Therapeutics Inc. The sale prices were between $37.06 and $47.11, with an estimated average price of $41.81.

Sold Out: Puma Biotechnology Inc (PBYI)

Great Point Partners Llc sold out a holding in Puma Biotechnology Inc. The sale prices were between $2.85 and $6.58, with an estimated average price of $4.28.



Here is the complete portfolio of GREAT POINT PARTNERS LLC. Also check out:

1. GREAT POINT PARTNERS LLC's Undervalued Stocks
2. GREAT POINT PARTNERS LLC's Top Growth Companies, and
3. GREAT POINT PARTNERS LLC's High Yield stocks
4. Stocks that GREAT POINT PARTNERS LLC keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

Request A Demo

Learn more about GuruFocus' key features, including All-In-One Screener, backtesting, 30-year financial, stock summary page, guru trades, insider trades, excel Add-in, google sheets and much more.

GuruFocus Screeners

Related Articles